Walnut Creek, California Clinical Trials

A listing of Walnut Creek, California clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 13 clinical trials
Safety Tolerability and Efficacy of the Human Cytomegalovirus Vaccine (V160) in Healthy Women 16 to 35 Years of Age (V160-002)

This study will evaluate the safety, tolerability, and efficacy of Human Cytomegalovirus (CMV) vaccine V160 administered in a 2-dose or 3-dose regimen in healthy seronegative women 16 to 35 years of age. Participants will receive blinded V160 on Day 1, Month 2, and Month 6 (3-dose regimen), V160 on Day …

Diablo Clinical Research, Inc ( Site 0009)
 (2.2 away) Contact site
  • 6476 views
  • 12 Aug, 2019
  • +95 other locations
Durvalumab Treatment in Combination With Chemotherapy and Bevacizumab Followed by Maintenance Durvalumab Bevacizumab and Olaparib Treatment in Advanced Ovarian Cancer Patients.

This is a Phase III randomised, double-blind, multi-centre study to evaluate the efficacy and safety of durvalumab in combination with standard of care platinum based chemotherapy and bevacizumab followed by maintenance durvalumab and bevacizumab or durvalumab, bevacizumab and olaparib in patients with newly diagnosed advanced ovarian cancer.

Research Site
 (0.7 away) Contact site
  • 84 views
  • 19 Nov, 2020
  • +279 other locations
A Mobile Health Intervention to Achieve Appropriate Gestational Weight Gain in Overweight/Obese Women

The aim of this trial is to investigate the effectiveness of a mobile health (mhealth) intervention to help overweight and obese women achieve appropriate gestational weight gain (GWG) for their pre-pregnancy body mass index (BMI). The goal of the intervention is to help women achieve GWG within the range recommended …

Kaiser Permanente Oakland
 (9.2 away) Contact site
  • 0 views
  • 22 Nov, 2020
  • +1 other locations
Intraoperative Radiation Therapy in Treating Patients With Breast Cancer Undergoing Breast-Conserving Surgery

This phase IV trial studies the side effects of intraoperative radiation therapy and how well it works in treating patients with breast cancer undergoing breast-conserving surgery. Delivering radiation one time to the area where the tumor was removed while the patient is still in the operating room may kill any …

cancer
breast cancer staging
tumor cells
John Muir Medical Center-Walnut Creek
 (2.2 away) Contact site
  • 101 views
  • 26 Jul, 2020
  • +25 other locations
Regional Radiotherapy in Biomarker Low Risk Node Positive Breast Cancer

The purpose of this study is to compare the effects on low risk breast cancer receiving usual care that includes regional radiation therapy, with receiving no regional radiation therapy. Researchers want to see if not giving this type of radiation treatment works as well at preventing breast cancer from coming …

adjuvant chemotherapy
invasive carcinoma
axillary lymph node dissection
hormone therapy
erbb2
Kaiser Permanente Oakland-Broadway
 (9.6 away) Contact site
  • 591 views
  • 20 Nov, 2020
  • +290 other locations
Axillary Reverse Mapping in Preventing Lymphedema in Patients With Breast Cancer Undergoing Axillary Lymph Node Dissection

This phase III trial studies how well axillary reverse mapping works in preventing lymphedema in patients with breast cancer undergoing axillary lymph node dissection. Axillary reverse mapping may help to preserve the lymph node drainage system around the breast so as to prevent lymphedema after surgery.

breast surgery
invasive breast cancer
isosulfan blue
mastectomy
ductal carcinoma in situ
Contra Costa Regional Medical Center
 (8.4 away) Contact site
  • 25 views
  • 25 Oct, 2020
  • +50 other locations
Study of Chemotherapy With Pembrolizumab (MK-3475) Followed by Maintenance With Olaparib (MK-7339) for the First-Line Treatment of Women With BRCA Non-mutated Advanced Epithelial Ovarian Cancer (EOC) (MK-7339-001/KEYLYNK-001/ENGOT-ov43/GOG-3036)

The purpose of this study is to assess the efficacy and safety of treatment with carboplatin/paclitaxel* PLUS pembrolizumab (MK-3475) and maintenance olaparib (MK-7339) in women with epithelial ovarian cancer (EOC), fallopian tube cancer, or primary peritoneal cancer. The primary study hypotheses are that the combination of pembrolizumab plus carboplatin/paclitaxel* followed …

ovarian epithelial carcinoma
interval debulking surgery
pembrolizumab
solid tumour
carcinosarcoma
Kaiser Permanente Oncology Clinical Trial - Walnut Creek ( Site 0080)
 (2.8 away) Contact site
  • 732 views
  • 25 Nov, 2020
  • +242 other locations
Breast Cancer WEight Loss Study (BWEL Study)

This randomized phase III trial studies whether weight loss in overweight and obese women may prevent breast cancer from coming back (recurrence). Previous studies have found that women who are overweight or obese when their breast cancer is found (diagnosed) have a greater risk of their breast cancer recurring, as …

cancer treatment
cancer
breast cancer, treatment
breast cancer
Epic Care Cyberknife Center
 (0.7 away) Contact site
  • 4083 views
  • 22 Nov, 2020
  • +1576 other locations
Increasing Patients' Engagement in Breast Cancer Surgery Decision-Making

This trial studies how well a breast cancer surgery decision aid works in increasing patient engagement in decision making for patients with newly diagnosed stage 0-III breast cancer. The trial also examines barriers to patient engagement even with the use of a decision aid, and if barriers are more likely …

breast surgery
hearing impairment
Epic Care Cyberknife Center
 (0.7 away) Contact site
  • 17 views
  • 18 Oct, 2020
  • +60 other locations
Cediranib Maleate and Olaparib or Standard Chemotherapy in Treating Patients With Recurrent Platinum-Resistant or -Refractory Ovarian Fallopian Tube or Primary Peritoneal Cancer

This randomized phase II/III trial studies how well cediranib maleate and olaparib work when given together or separately, and compares them to standard chemotherapy in treating patients with ovarian, fallopian tube, or primary peritoneal cancer that has returned (recurrent) after receiving chemotherapy with drugs that contain platinum (platinum-resistant) or continued …

cediranib
tumor cells
bevacizumab
vegf
ovarian cancer
Kaiser Permanente-Walnut Creek
 (0.7 away) Contact site
  • 1729 views
  • 27 Nov, 2020
  • +211 other locations